CAR T-Cell Therapy for Large B-Cell Lymphoma

Practical information for the advanced practitioner on a revolutionary cancer treatment

This supplement to JADPRO, developed in partnership with Nexus Global Group Science LLC, aims to provide practical information to advanced practitioners on a number of considerations when implementing CAR T-cell therapy. It is sponsored by Kite, a Gilead Company.


Editorial

CAR T-Cell Therapy for Large B-Cell Lymphoma

Maritza C. Alencar, DNP, MBA, APRN-BC, BMTCN®

Read More
Review Article

Anti-CD19 CAR T-Cell Therapy for Adult Patients With Refractory Large B-Cell Lymphoma

Kathleen McDermott, RN, BSN, OCN®, BMTCN®, and Lauren Spendley, AGNP, MSN, AOCN®

Read More
Review Article

CAR T-Cell Therapy: Adverse Events and Management

Sherry Adkins, RN, MSN, ANP-C

Read More
Review Article

Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-Cell Therapy

Alix Beaupierre, RN, BSN, OCN®, Nicole Kahle, MS, RN, OCN®, BMTCN®, Rachel Lundberg, PA-C, MPAS, and Amy Patterson, MSN, APRN, AOCNS®, BMTCN®

Read More
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.